By Andrew Westney ( May 30, 2014, 3:58 PM EDT) -- Teva Pharmaceutical Industries Ltd. has kept exclusive rights to market its generic version of Pfizer Inc.'s arthritis drug Celebrex, as a West Virginia federal judge ruled Thursday that the U.S. Food and Drug Administration didn't overstep its bounds in denying an exclusivity share to other generic-drug makers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.